HURRICANE CAPITAL ADVISORS LLC’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Hold
4,300
– – 0.05% 326
2026
Q1
$237K Sell
4,300
-600
-12% -$32.5K 0.07% 238
2025
Q4
$240K Sell
4,900
-500
-9% -$23.3K 0.08% 237
2025
Q3
$233K Sell
5,400
-300
-5% -$11.7K 0.06% 265
2025
Q2
$219K Buy
5,700
+1,012
+22% +$38.7K 0.05% 235
2025
Q1
$182K Hold
4,688
– – 0.06% 213
2024
Q4
$159K Buy
4,688
+300
+7% +$10.8K 0.05% 245
2024
Q3
$179K Hold
4,388
– – 0.06% 228
2024
Q2
$169K Buy
4,388
+500
+13% +$21K 0.06% 220
2024
Q1
$167K Hold
3,888
– – 0.05% 255
2023
Q4
$144K Buy
+3,888
New +$140K 0.06% 210

Other funds holding GSK

HURRICANE CAPITAL ADVISORS LLC's GSK Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC held its GSK (GSK) position steady in Q2 2026 at 4,300 shares worth $225K. The position accounts for 0.05% of the portfolio, ranked #326.

HURRICANE CAPITAL ADVISORS LLC first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $240K in Q4 2025. 1,050 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 4,300 shares of GSK worth $225K as of Q2 2026.
  • HURRICANE CAPITAL ADVISORS LLC left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.05% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #326 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • HURRICANE CAPITAL ADVISORS LLC's GSK position peaked at $240K in Q4 2025.
  • 1,050 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.